AMPKα1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling

Journal of Leukocyte Biology

Volumn 94, Issue 6, 2013, Pages 1113-1121

  Carroll, Kelly Casey ^a   Viollet, Benoit ^b,c,d   Suttles, Jill ^a  

^a University of Louisville School of Medicine   (United States)

^b INSTITUT COCHIN   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antigen processing presentation; Costimulation; DC; Inflammation; Monocytes macrophages; Th1 Th2 cells

Indexed keywords

ADENYLATE KINASE; ADENYLATE KINASE ALPHA1; CD40 ANTIGEN; CD40 LIGAND; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 10; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ADENYLATE KINASE ALPHA1 DEFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEFICIENCY; ENZYME PHOSPHORYLATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

ANTIGEN PROCESSING/PRESENTATION; COSTIMULATION; DC; INFLAMMATION; MONOCYTES/MACROPHAGES; TH1/TH2 CELLS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTERLEUKIN-17; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MYELOID CELLS; TH1 CELLS; TH17 CELLS; TRANSCRIPTION FACTOR RELA;

EID: 84888794082     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0313157     Document Type: Article

References (50)

1. Hardie, D. G., Carling, D. (1997) The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 246, 259-273
2. Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., Hardie, D. G. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879-27887.
3. Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., Carling, D. (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004-2008.
4. Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Makela, T. P., Alessi, D. R., Hardie, D. G. (2003) Complexes between the LKB1 tumor suppressor, STRAD/ and MO25/ are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28.
5. Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., Cantley, L. C. (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 101, 3329-3335
6. Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., Hardie, D. G. (2005) Calmodulin-dependent protein kinase kinaseis an alternative upstream kinase for AMP-activated protein kinase. Cell. Metab. 2, 9-19.
7. Woods, A., Dickerson, K., Heath, R., Hong, S. P., Momcilovic, M., Johnstone, S. R., Carlson, M., Carling, D. (2005) Ca2 /calmodulin-dependent protein kinase kinaseacts upstream of AMP-activated protein kinase in mammalian cells. Cell. Metab. 2, 21-33.
8. Hurley, R. L., Anderson, K. A., Franzone, J. M., Kemp, B. E., Means, A. R., Witters, L. A. (2005) The Ca2 /calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280, 29060-29066.
9. Carling, D., Clarke, P. R., Zammit, V. A., Hardie, D. G. (1989) Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutarylCoA reductase kinase activities. Eur. J. Biochem. 186, 129-136.
10. Carling, D., Thornton, C., Woods, A., Sanders, M. J. (2012) AMP-activated protein kinase: new regulation, new roles? Biochem. J. 445, 11-27.
11. Nath, N., Giri, S., Prasad, R., Salem, M. L., Singh, A. K., Singh, I. (2005) 5-Aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J. Immunol. 175, 566-574.
12. Suzuki, J., Yoshimura, T., Simeonova, M., Takeuchi, K., Murakami, Y., Morizane, Y., Miller, J. W., Sobrin, L., Vavvas, D. G. (2012) Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 53, 4158-4169.
13. Bai, A., Ma, A. G., Yong, M., Weiss, C. R., Ma, Y., Guan, Q., Bernstein, C. N., Peng, Z. (2010) AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. Biochem. Pharmacol. 80, 1708-1717.
14. Jhun, B. S., Jin, Q., Oh, Y. T., Kim, S. S., Kong, Y., Cho, Y. H., Ha, J., Baik, H. H., Kang, I. (2004) 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochem Biophys Res Commun. 318, 372-80.
15. Kuo, C. L., Ho, F. M., Chang, M. Y., Prakash, E., Lin, W. W. (2008) Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase. J Cell Biochem. 103, 931-40.
16. Sag, D., Carling, D., Stout, R. D., Suttles, J. (2008) Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633-8641.
17. Yang, Z., Kahn, B. B., Shi, H., Xue, B. Z. (2010) Macrophage 1 AMP-activated protein kinase (1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J. Biol. Chem. 285, 19051-19059.
18. Galic, S., Fullerton, M. D., Schertzer, J. D., Sikkema, S., Marcinko, K., Walkley, C. R., Izon, D., Honeyman, J., Chen, Z. P., van Denderen, B. J., Kemp, B. E., Steinberg, G. R. (2011) Hematopoietic AMPK 1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J. Clin. Invest. 121, 4903-4915.
19. Krawczyk, C. M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R. J., Cross, J. R., Jung, E., Thompson, C. B., Jones, R. G., Pearce, E. J. (2010) Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742-4749.
20. Meares, G. P., Qin, H., Liu, Y., Holdbrooks, A. T., Benveniste, E. N. (2013) AMP-activated protein kinase restricts IFN-γ signaling. J. Immunol. 190, 372-380.
21. Cao, Y., Li, H., Liu, H., Zheng, C., Ji, H., Liu, X. (2010) The serine/ threonine kinase LKB1 controls thymocyte survival through regulation of AMPK activation and Bcl-XL expression. Cell. Res. 20, 99-108.
22. Tamas, P., Macintyre, A., Finlay, D., Clarke, R., Feijoo-Carnero, C., Ashworth, A., Cantrell, D. (2010) LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells. Eur. J. Immunol. 40, 242-253.
23. Rolf, J., Zarrouk, M., Finlay, D. K., Foretz, M., Viollet, B., Cantrell, D. A. (2013) AMPK 1: a glucose sensor that controls CD8 T-cell memory. Eur. J. Immunol. 43, 889-896.
24. MacIver, N. J., Blagih, J., Saucillo, D. C., Tonelli, L., Griss, T., Rathmell, J. C., Jones, R. G. (2011) The liver kinase B1 is a central regulator of T cell development, activation, and metabolism. J. Immunol. 187, 4187-4198.
25. Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., Rathmell, J. C. (2011) Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4 T cell subsets. J. Immunol. 186, 3299-3303.
26. Viollet, B., Andreelli, F., Jorgensen, S. B., Perrin, C., Flamez, D., Mu, J., Wojtaszewski, J. F., Schuit, F. C., Birnbaum, M., Richter, E., Burcelin, R., Vaulont, S. (2003) Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem. Soc. Trans. 31, 216-219.
27. Reynolds, J. M., Liu, Q., Brittingham, K. C., Liu, Y., Gruenthal, M., Gorgun, C. Z., Hotamisligil, G. S., Stout, R. D., Suttles, J. (2007) Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis. J. Immunol. 179, 313-321.
28. Suttles, J., Stout, R. D. (2009) Macrophage CD40 signaling: a pivotal regulator of disease protection and pathogenesis. Semin. Immunol. 21, 257-264.
29. Stout, R. D., Suttles, J. (1996) The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today 17, 487-492.
30. Mukundan, L., Milhorn, D. M., Matta, B., Suttles, J. (2004) CD40-mediated activation of vascular smooth muscle cell chemokine production through a Src-initiated, MAPK-dependent pathway. Cell. Signal. 16, 375-384.
31. Mukundan, L., Bishop, G. A., Head, K. Z., Zhang, L., Wahl, L. M., Suttles, J. (2005) TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. J. Immunol. 174, 1081-1090.
32. Suttles, J., Milhorn, D. M., Miller, R. W., Poe, J. C., Wahl, L. M., Stout, R. D. (1999) CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (IL)-4 and IL-10 anti-inflammatory action. J. Biol. Chem. 274, 5835-5842.
33. Tsukamoto, N., Kobayashi, N., Azuma, S., Yamamoto, T., Inoue, J. (1999) Two differently regulated nuclear factor B activation pathways triggered by the cytoplasmic tail of CD40. Proc. Natl. Acad. Sci. USA 96, 1234-1239.
34. Aicher, A., Shu, G. L., Magaletti, D., Mulvania, T., Pezzutto, A., Craxton, A., Clark, E. A. (1999) Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J. Immunol. 163, 5786-5795.
35. Pearson, L. L., Castle, B. E., Kehry, M. R. (2001) CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptorassociated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways. Int. Immunol. 13, 273-283.
36. Motoshima, H., Goldstein, B. J., Igata, M., Araki, E. (2006) AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J. Physiol. 574, 63-71.
37. Grimes, C. A., Jope, R. S. (2001) CREB DNA binding activity is inhibited by glycogen synthase kinase-3 and facilitated by lithium. J. Neurochem. 78, 1219-1232.
38. Martin, M., Rehani, K., Jope, R. S., Michalek, S. M. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777-784.
39. Alessi, D. R., Deak, M., Casamayor, A., Caudwell, F. B., Morrice, N., Norman, D. G., Gaffney, P., Reese, C. B., MacDougall, C. N., Harbison, D., Ashworth, A., Bownes, M. (1997) 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7, 776-789.
40. Stephens, L., Anderson, K., Stokoe, D., Erdjument-Bromage, H., Painter, G. F., Holmes, A. B., Gaffney, P. R., Reese, C. B., McCormick, F., Tempst, P., Coadwell, J., Hawkins, P. T. (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710-714.
41. Sarbassov, D. D., Guertin, D. A., Ali, S. M., Sabatini, D. M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
42. Inoki, K., Zhu, T., Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590.
43. Inoki, K., Li, Y., Zhu, T., Wu, J., Guan, K. L. (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648-657.
44. Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., Cantley, L. C. (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/ akt pathway. Mol. Cell. 10, 151-162.
45. Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., Blenis, J. (2002) Tuberous sclerosis complex-1 and-2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. USA 99, 13571-13576.
46. Zhang, H. H., Lipovsky, A. I., Dibble, C. C., Sahin, M., Manning, B. D. (2006) S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol. Cell. 24, 185-197.
47. O'Neill, L. A., Hardie, D. G. (2013) Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493, 346-355.
48. Rodriguez-Prados, J. C., Traves, P. G., Cuenca, J., Rico, D., Aragones, J., Martin-Sanz, P., Cascante, M., Bosca, L. (2010) Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 185, 605-614.
49. Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., Chi, H. (2011) HIF1-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367-1376.
50. Dang, E. V., Barbi, J., Yang, H. Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H. R., Luo, W., Zeller, K., Shimoda, L., Topalian, S. L., Semenza, G. L., Dang, C. V., Pardoll, D. M., Pan, F. (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146, 772-784.